A TOXICITY STUDY OF RECOMBINANT INTERFERON-GAMMA GIVEN BY INTRAVENOUS-INFUSION TO PATIENTS WITH ADVANCED CANCER

被引:35
|
作者
SRISKANDAN, K
GARNER, P
WATKINSON, J
PETTINGALE, KW
BRINKLEY, D
CALMAN, FMB
TEE, DEH
机构
[1] UNIV LONDON KINGS COLL HOSP, SCH MED, DEPT IMMUNOL, DENMARK HILL, LONDON SE5 9RS, ENGLAND
[2] UNIV LONDON KINGS COLL HOSP, SCH MED, DEPT MED, LONDON SE5 9RS, ENGLAND
[3] UNIV LONDON KINGS COLL HOSP, SCH MED, DEPT RADIOTHERAPY, LONDON SE5 9RS, ENGLAND
关键词
D O I
10.1007/BF00253067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:63 / 68
页数:6
相关论文
共 50 条
  • [1] TOXICITY OF HUMAN RECOMBINANT INTERFERON-GAMMA IN RATS AND DOGS
    YUAN, BJ
    FANG, YQ
    LIU, JP
    LU, GC
    YANG, YM
    ZHOU, GX
    ACTA PHARMACOLOGICA SINICA, 1995, 16 (04) : 308 - 310
  • [2] CONTINUOUS INTRAVENOUS-INFUSION PHARMACOKINETICS OF INTERFERON TO PATIENTS WITH LEUKEMIA
    WILLS, RJ
    SPIEGEL, HE
    JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (08): : 616 - 619
  • [3] PHASE-I STUDY OF A COMBINATION OF RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS
    KURZROCK, R
    ROSENBLUM, MG
    QUESADA, JR
    SHERWIN, SA
    ITRI, LM
    GUTTERMAN, JU
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) : 1677 - 1683
  • [4] Recombinant interleukin-2 in combination with recombinant interferon-gamma in patients with advanced malignancy: A Phase 1 study
    Reddy, SP
    Harwood, RM
    Moore, DF
    Grimm, EA
    Murray, JL
    VadhanRaj, S
    JOURNAL OF IMMUNOTHERAPY, 1997, 20 (01): : 79 - 87
  • [5] COMPARISON OF TOXICITY OF 4 INOTROPIC CATECHOLAMINES GIVEN BY CONTINUOUS INTRAVENOUS-INFUSION TO DOGS
    MEYERS, DB
    SHOUFLER, JR
    TODD, GC
    GIBSON, WR
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1978, 45 (01) : 228 - 229
  • [6] COMPARATIVE CARDIOVASCULAR TOXICITY IN DOGS GIVEN INOTROPIC AGENTS BY CONTINUOUS INTRAVENOUS-INFUSION
    SANDUSKY, GE
    MEANS, JR
    TODD, GC
    TOXICOLOGIC PATHOLOGY, 1990, 18 (02) : 268 - 278
  • [7] CORONARY VASCULAR TOXICITY IN DOGS GIVEN INOTROPIC AGENTS BY CONTINUOUS INTRAVENOUS-INFUSION
    SANDUSKY, GE
    MEANS, JR
    TODD, GC
    LABORATORY INVESTIGATION, 1989, 60 (01) : A83 - A83
  • [8] RECOMBINANT HUMAN GAMMA-INTERFERON ADMINISTERED BY CONTINUOUS INTRAVENOUS-INFUSION IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
    STONE, RM
    SPRIGGS, DR
    ARTHUR, KA
    MAYER, RJ
    GRIFFIN, J
    KUFE, DW
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (02): : 159 - 163
  • [9] A PHASE-I TRIAL WITH RECOMBINANT INTERFERON-GAMMA (ROUSSEL UCLAF) IN ADVANCED CANCER-PATIENTS
    BOUE, F
    PASTRAN, Z
    SPIELMANN, M
    LECHEVALIER, T
    SUBIRANA, R
    SEVIN, D
    PAOLETTI, C
    BRANDELY, M
    AVRIL, MF
    SANCHOGARNIER, H
    TURSZ, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 32 (01) : 67 - 70
  • [10] TOXICITY OF RECOMBINANT HUMAN INTERLEUKIN-2 IN RATS FOLLOWING INTRAVENOUS-INFUSION
    MATORY, YL
    CHANG, AE
    LIPFORD, EH
    BRAZIEL, R
    HYATT, CL
    MCDONALD, HD
    ROSENBERG, SA
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1985, 4 (04): : 377 - 390